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Abstract 
Cardiac mechanics plays a crucial role in atrial and ventricular function, in the regulation of growth 
and remodelling, in the progression of disease, and the response to treatment. The spatial scale of 
the critical mechanisms ranges from nm (molecules) to cm (hearts) with the fastest events occurring 
in milliseconds (molecular events) and the slowest requiring months (growth and remodelling). Due 
to its complexity and importance, cardiac mechanics has been studied extensively both 
experimentally and through mathematical models and simulation.  
Models of cardiac mechanics evolved from seminal studies in skeletal muscle, and developed into 
cardiac specific, species specific, human specific and finally patient specific calculations. These 
models provide a formal framework to link multiple experimental assays recorded over nearly 100 
years into a single unified representation of cardiac function. This review first provides a summary of 
the proteins, physiology and anatomy involved in the generation of cardiac pump function. We then 
describe the evolution of models of cardiac mechanics starting with the early theoretical frameworks 
describing the link between sarcomeres and muscle contraction, transitioning through myosin-level 
models to calcium-driven systems, and ending with whole heart patient-specific models. 
 
Introduction 
Cardiac Physiology 
The central function of the heart is to circulate blood throughout the body. Blood flow results from 
the combined action of the cardiac valves and rhythmic contractions of the heart’s four chambers. 
Pumping movement by the chambers is made possible by a high density of contractile cells within 
the chamber walls. These muscle cells or cardiomyocytes are in turn packed with dense arrays of 
contractile structures known as sarcomeres.  
The sarcomere is the smallest functional unit of contraction. It is comprised of so-called thick and 
thin filaments that are arranged in large parallel arrays [1]. Each thick filament is typically 
surrounded by six thin filaments in a repeating pattern that forms a highly organized lattice. With 
the two filament systems thus interdigitated, they can slide past one another [2]. Their proximity 
also allows the myosin motor proteins that protrude from the thick filament to attach to binding 
sites on the thin filament. When such an attachment forms, it creates a mechanical link between 
thick and thin filaments known as a crossbridge [3-5]. Once a crossbridge forms, myosin undergoes 
an ATP-driven molecular rearrangement called a powerstroke that distorts the crossbridge and 
creates a pulling force that tends to slide the thin and thick filaments past each other [6, 7]. After the 
powerstroke and binding of a new ATP molecule to the myosin head, it releases from the thin 
filament. As sufficient numbers of myosin heads cyclically attach to, pull on, and detach from thin 
filaments, the sarcomere contracts. 
As a pulsatile pump, the heart requires a system for precise activation and deactivation of contractile 
activity in the sarcomeres. A heart beat is the result of an electrical signal that passes through the 
myocardium, triggering within each cell a transient increase in Ca2+ concentration [8].  Ca2+ ions are 
the essential control signal that activates contraction at the level of the sarcomere [9]. The Ca2+ 
signal is transduced by the thin filaments [10], which contain proteins that form a sensitive and 
highly tuned allosteric signalling complex (reviewed in [11]). The thin filaments are composed of an 
actin filament backbone decorated with accessory proteins that include tropomyosin and the three 
subunits of troponin (C, I, and T) [12]. Tropomyosin is an elongated coiled-coil dimer that spans 
seven actin subunits [13]. Under conditions of low Ca2+, tropomyosin blocks myosin binding sites on 
actin and prevents crossbridge formation. This is the relaxed state of the sarcomere. When Ca2+ is 
present, it binds to a single site on troponin C and triggers a series of conformational changes in the 
troponin-tropomyosin-actin complex. The end result is movement of tropomyosin azimuthally on 
the surface of actin to expose myosin binding sites, and contraction is initiated [14]. The Ca2+ 
transient recovers as Ca2+ is removed from the cytosol by the sarcoplasmic reticulum Ca2+ -ATPase 
and the membrane sodium/calcium exchanger. Ca2+ recovery starts prior to peak tension. As the Ca2+ 
transient falls, Ca2+ dissociates from troponin C, in turn allowing tropomysoin to return to its blocked 
position, inhibiting crossbridge binding. 
Macroscopically, sarcomeres constitute a bulk material with anisotropic, time-varying mechanical 
properties [15]. The activity of myosin ATPase makes the sarcomere a unique class of ‘active’ 
material, capable of producing mechanical work. Components within the sarcomere also provide 
passive mechanical elements that contribute to the material properties of myocardium, such as the 
giant protein titin [16]. Titin acts as a molecular spring in parallel with the freely sliding thick and thin 
filaments, providing mechanical stability to the sarcomere during relaxation. 
Both passive and active components of the sarcomeres are linked to the cell exterior through a host 
of additional structural proteins [17] that connect cardiomyocytes to the extracellular matrix and 
adjacent cells. The brick-shaped cardiomyocytes are arranged with their long axes oriented along a 
common axis to form the fibres and sheets of contractile tissue that comprise the chamber walls 
[18]. Hence, sarcomeres are mechanically linked across scales to the fluid loads within the heart. The 
activity of myosin is thereby capable of exerting mechanical forces on blood to generate ejection 
during systole. By the same token, blood filling the chambers during diastole acts to stretch the 
relaxed sarcomeres and modify their behaviour – as sarcomere length changes, the configuration of 
its constituent proteins is altered [19] and contraction force is modulated such that contractions 
initiated at longer sarcomere lengths produce more force  [20-23]. This phenomenon, known at the 
ventricular level as the Frank-Starling relationship, is often referred to as length-dependent 
activation, and has been studied experimentally by numerous groups. The precise mechanisms 
remain unclear (see [24, 25]) but may include length-dependent changes in myofibrillar lattice 
spacing [26], strain-sensitive interactions within and between troponin and tropomyosin [27], and 
interactions between titin and the thick and thin filaments [28]. A new hypothesis that has been 
developed in the last few years suggests that length-dependent activation is caused by stretch-
induced changes in thick filament structure [29-32]. 
Ultimately, the proteins of the sarcomere and their structural arrangement impart dependencies of 
time, Ca2+, sarcomere length, rate of sarcomere length change (i.e. velocity), and load to the 
mechanical properties of the myocardium. These relationships have been painstakingly elucidated 
through many decades of biomechanical testing of cardiac tissue preparations that include whole 
ventricles, intact trabeculae or papillary muscles, individual cardiomyocytes, and ultimately isolated 
myofibrils (Figure 1).  
The complex and dynamic material properties of myocardium, in conjunction with the three-
dimensional configuration of the myocardial fibres, underpin the complex tissue mechanics of the 
contracting myocardium [33]. The challenging task of creating models to accurately describe the 
multivariate properties of myocardial mechanics spans nearly a century (Figure 2). These efforts 
have been driven by the opportunity to gain mechanistic insights into cardiac physiology and 
formulate simulations with sufficient accuracy to find use in clinical applications.  
 
Tissue Based Models of Contraction 
Determining the start of any field is contentious. However, the study by A.V. Hill in 1938 [34] 
described fundamental properties of muscle mechanics that continue to inform muscle physiology 
studies today. In a series of elegant experiments, Hill related the release of energy by muscle, the 
mechanical work performed by the muscle, the force of contraction and the velocity of shortening. 
Hill was able to develop a phenomenological ‘rheological’ model that linked these four variables and 
derive the characteristic force velocity curve that is now named after him. He also predicted the 
velocity where peak power will be generated. While the relationship between force and velocity are 
crucial for muscle physiology, Hill was unable to identify the mechanism that would explain their 
relationship. 
In 1957, Huxley combined recent electron microscopy data with the concept of a crossbridge to 
develop the first model of tension generation based on protein dynamics [35]. Crossbridges were 
modelled as bound or unbound with the binding and unbinding rates of crossbridges and actin 
depending on how far the crossbridge was distorted from its reference state. These spatially varying 
crossbridge kinetics allowed Huxley’s model to recapitulate Hill’s force -velocity relationship. The 
initial model was subsequently extended by Huxley and Simmons [6] to include multiple bound 
configurations. This allowed the model to reproduce the complex time course of force recovery 
when a tetanized muscle fiber is subjected to rapid changes in length. 
Modelling the Biochemistry of Contraction  
The ability to isolate and measure myosin, actin, ATP and ADP advanced understanding of muscle 
physiology by allowing the biochemistry of contraction to be studied and subsequently modelled. 
The initial experiments underpinned enzyme reaction schemes that reflected the biochemical steps 
of tension generation. Eisenberg and Moos [36] performed a kinetic analysis of actin and heavy 
meromysoin (the end of the myosin molecule that contains the crossbridge head) and proposed a 4 
step cyclical reaction involving actin, myosin and ATP. Lymn and Taylor [37] combined a biochemical 
description of actin-myosin reactions with a mechanical model of crossbridge force generation to 
link tension generation with biochemistry. Stein et al., [38] demonstrated that ATP can be 
metabolised while myosin was still bound to actin. This was inconsistent with the Lymn and Taylor 
framework. To address this discrepancy Stein et al., proposed a 12 state model of actin – myosin 
interactions and proposed that crossbridges can bind to actin in multiple states, consistent with the 
Huxley and Simons model. Stein et al., grouped these states into two sets of crossbridges that were 
described as strong and weakly bound. Eisenberg et al., [39] expanded the 12 state Stein et al., 
biochemical actin-myosin model to include velocity dependence and the response to rapid length 
steps, linking the observations of Hill and Huxley and Simmons to molecular events. A crossbridge 
kinetic model specific to cardiac myosin isoforms was recently formulated by Mijailovich and 
coworkers [40]. 
Modelling the Foundations of Muscle Activation  
The insight that free Ca2+ activates actin-myosin interaction was first clearly demonstrated by A. 
Weber in 1959 [9] and subsequently led to new experiments and models. In 1969 Julian proposed a 
model of transient muscle tension generation [41]. This was an astounding advance given the field’s 
limited knowledge of intracellular Ca2+ signalling. Julian’s model used a transient activation variable 
to drive a Huxley model and calculated the distribution of bound crossbridges during a muscle 
twitch. Greene and Eisenberg [42] observed that crossbridge binding was cooperative and that 
cooperative activation can occur even in the absence of Ca2+. This led them to propose a biochemical 
crossbridge model that included weakly and strongly bound crossbridges and cooperative binding. 
Subsequently, Terrell Hill [43] developed a reduced model that represented thin filament 
Ca2+ activation, thin filament cooperativity, crossbridge binding and crossbridge biochemistry and 
thereby captured many of the processes involved in Ca2+-dependent regulation of force. 
A crucial addition to understanding and modelling the thin filament was later contributed by 
McKillop and Geeves, who used biochemical studies of cooperative myosin binding to predict three 
states of the thin filament regulatory unit (blocked, closed, and open) [44]. A prime example of using 
model analysis to elucidate molecular mechanisms, their three-state model was subsequently 
supported by electron microscopy studies that identified three distinct azimuthal positions of 
tropomyosin corresponding to Ca2+-free, Ca2+-bound, and myosin-bound conditions [14]. The three-
state thin filament regulatory unit model would subsequently be incorporated into numerous 
models of cardiac muscle contraction. 
The early use of models to study cardiac tissue 
One of the early applications of mathematical models to study cardiac muscle contraction was 
performed by Parmley and Sonnenblick [45] in 1967. They used variations of A.V. Hill’s rheological 
model to interpret the passive and active components of cardiac tissue mechanics and deduced 
properties for these components from measurements of muscle’s length-tension relationship. Fung 
[46] subsequently combined a Hill rheological model, a geometric description of filaments and force-
velocity curves to create a model of cardiac muscle tension generation driven by an as yet unknown 
activation variable. 
The development of rapid oscillation techniques in skeletal muscle by Kawai and Brandt [47] allowed 
the kinetics of muscle biochemistry and muscle mechanics to be studied at the same time. Saeki et 
al. [48, 49] used barium contracture sinusoidal analysis to evaluate two variants of A.V. Hill’s 
rheological model to determine the relationship between passive and active components of cardiac 
muscle. Sinusoidal analysis was subsequently applied under conditions of differing ATP and inorganic 
phosphate to link muscle tension dynamics to biochemical reaction rates in a 7 state crossbridge 
binding model [50]. Finally, Robertson et al., [51] proposed a model of cardiac thin filament 
activation in the form of Ca2+ binding to troponin C. This model was then used extensively for 
Ca2+ troponin C activation in subsequent contraction models. 
Modelling thin filament cooperativity  
Following observations of thin filament cooperativity [13] and tropomyosin end-to-end 
polymerization [52], Terrell Hill et al. [53] used the Ising framework to develop a cooperative model 
of  interactions between tropomyosin molecules. This required periodic boundary conditions and a 
limited number of states. To address these concerns Terrell Hill et al., [54] proposed a more 
elaborate multi-state cooperative model of actin filament activation and crossbridge biochemistry. 
Unfortunately, the calculations were too complex to solve with the computing resources available at 
the time and the work was published as an unsolved theoretical model. Derivatives of these original 
models would eventually be included in subsequent cardiac mechanics models. Advances in 
computing power and the use of a cellular automata model allowed Zou and Phillips [55] to simulate 
tropomyosin neighbour – neighbour interactions and recapitulate the high cooperativity observed in 
muscle contraction activation. Dobrunz et al., [56] developed a cooperative neighbour-neighbour 
steady-state model representing explicit regulatory units consisting of 7 actin monomers, a 
crossbridge, a tropomyosin molecule and the troponin complex. Simulating this system with a 
simplified network of 9 regulatory units required a system of equations with 262,144 states. A real 
thin filament, spanning a half sarcomere, has on the order of 26 regulatory units [57] so explicit 
calculations are likely to overwhelm most computational resources. An alternative was proposed by 
Smith et al., [58] who represented overlapping tropomyosin molecules as a single continuous chain. 
The introduction of a bending energy term effectively penalized neighbours with different locations 
to recapitulate end-to-end cooperativity of tropomyosin. Cooperative models of the thin filament 
based on tropomyosin overlap were subsequently supported by single-molecule fluorescence 
studies showing myosin binding in contiguous stretches to regulated actin [59]. 
Physiological cardiac mechanics sarcomere models  
The first model linking Ca2+ dynamics to cardiac contraction was published by Panerai in 1980 [60]. 
They prescribed a Ca2+ transient that drove a nonlinear mass action model of actin activation, which 
was in turn used as an input to a two state crossbridge model. The simulations predicted tension, 
force-length relationships and oxygen consumption. Guccione and McCulloch [61] developed a 
cardiac contraction model that represented the known length dependence of tension but moved 
away from the Huxley crossbridge formulation to provide a model described entirely by ordinary 
differential equations. This work was paralleled by Landesberg and Sidemen who developed a model 
of contraction coupled to a model of intracellular Ca2+ regulation [62]. In 1998 Hunter et al. [63] 
published a succinct model of tension generation that combined a biophysical model of thin filament 
kinetics coupled with a fading memory model of crossbridge kinetics. The Hunter model was one of 
the earliest designed to drive large deformation mechanics models of tissue and whole heart 
function. In the following year, Rice et al., [64] published a collection of cardiac contraction models 
aimed at exploring the different potential roles of thin filament and crossbridge cooperativity in 
tension generation.  
The Rice and Hunter models did not include velocity dependence or represented this dependence 
with a phenomenological model. Razumova et al., [65] subsequently enhanced a distortion model 
originally developed by Thorson and White [66] to calculate forces produced by crossbridges in 
multiple states. The framework could be represented as a system of ordinary differential equations 
thereby enhancing computational efficiency. Alternative approaches to efficiently represent 
crossbridge population dynamics have been achieved and used to study the role of tissue strain rate 
in cardiac twitch relaxation [67]. 
As models matured there was a growing need to strengthen the links between model parameters, 
validation, and experimental data. This led Niederer at al., [68] to develop the first contraction 
model that was based on a set of species and temperature consistent data. These ideas were 
subsequently extended by Rice et al., [69] who identified the key parameters that could be tuned to 
create contraction models for different species and distinct experimental conditions. Next, S.G. 
Campbell built on Eisenberg’s research focused on skeletal muscle in the 1980s to create a model of 
cardiac thin filament cooperativity [70]. Computational cost limited simulations of S.G. Campbell’s 
model to 11 regulatory units but Land and Niederer [71] proposed a variation that included a 
continuous chain model of tropomyosin and could simulate a full length filament. Recent 
developments include Land et al.’s data-driven contractile models for human cardiac myocytes, 
trabeculae and ventricles [72], and Tewari et al.’s simulations that recapitulate the ATP and Pi 
dependence of dynamic stiffness [73]. 
Computational cost has also been the main weakness of spatially-explicit models. These simulate 
contraction by keeping track of the state and location of each molecule in the sarcomeric lattice. To 
our knowledge, the first spatially-explicit model was developed by Daniel et al. in 1998 [74] but 
several other groups have now developed similar frameworks [75-77]. One advantage of the 
approach is that it provides a way of modeling compliant realignment, the vernier-like adjustments 
in the relative positions of actin and myosin molecules that accompany force development [74]. This 
is an area of active research and advances in experimental techniques for X-ray diffraction and 
analysis are providing new insights into the compliance of the thick and thin filaments [78] and 
potential non-linearities in myosin stiffness [79]. 
Coupling Models of Activation to Tension Generation 
An innovative electromechanics model was developed by Kaufmann et al., [80] in 1974 who linked 
analog circuit models of electrophysiology and tension generation by literally hard-wiring the circuits 
together. The first coded models either combined simplified Ca2+ handling models with complex 
contraction systems, or complex electrophysiology systems with simplified contraction models [81-
83]. Models that integrated detailed electrophysiological and contractile models needed to wait for 
improvements in computational power. Initial attempts in this area focused on simulating emergent 
behaviour without strict validation of model predictions [84, 85]. Subsequent validated models by 
S.G. Campbell et al., [86] and Niederer and Smith [87] analysed the effects of Ca2+ dynamics and 
sarcomere heterogeneity, and the slow force response, respectively. Zhang et al., [88] have recently 
reported a finite element model of the rat left ventricle driven by a detailed sarcomeric model that 
agreed closely with experimentally measured tissue strains and pressure-volume characteristics. 
However, such detailed validation is not universal. The number of variables, the disparate data sets 
and the challenge of model validation has limited the development of this field to date. Many 
studies now couple previously developed models of electrophysiology and contraction together 
without model specific validation. 
Whole Organ Modelling 
Cardiac mechanics can be approached from the bottom up, scaling from molecules to the heart. An 
alternative approach is to start at the top by simulating the mechanics of the ventricle. In 1979 Arts 
et al., [89] proposed an early ventricular model which mimicked transmural variation in fiber 
orientation using a set of thick walled cylinders. Humphrey and Yin [90] subsequently extended this 
approach with the first truncated ellipse model of the heart. Guccione et al., [91] returned to 
modelling the ventricle as a cylinder but introduced the finite element method to solve the large 
deformation mechanics equations. Anatomical detail was included in a subsequent iteration of this 
model and Guccione et al., [92] were able to predict strain in a circumferentially symmetric model of 
the left ventricle and validate their results using experimental data. Nash and Hunter [93], made a 
significant step forward in whole organ modelling, with the first biventricular model that integrated 
detailed fibre orientation and biophysical contraction. 
Many of these early whole organ models were used to study cardiac physiology. The Arts group 
developed a truncated ellipse model of left ventricular electromechanics [94-96] that combined a 
phenomenological contraction model with an Eikonal activation pattern. They used this approach to 
interpret canine asynchronous activation patterns and to test how modulating the activation would 
alter whole organ mechanics. More recently, detailed biophysical models of contraction and 
electrophysiology have been used by Land et al., [97-99] to study the link between sarcomere 
dynamics and whole organ contraction, and to investigate the impact of eliminating SERCA which 
plays a crucial role in regulating intracellular Ca2+. Finally, Lumens et al., have developed a spectrum 
of models for simulating cardiac mechanics using a 1-2D representation of the ventricles [100]. Their 
simplified model captures many of the salient physiological attributes while remaining exceptionally 
fast to solve. As a result, it is now widely used to help interpret clinical data.  
Patient Specific Models: Inferring Material Properties  
One application of cardiac modelling is to deduce material properties from clinical images. Wang et 
al., [101] demonstrated that this was possible in dogs by calculating passive material properties from 
MRI data. This approach was subsequently extended to humans by Xi et al., [102, 103] using data 
from two patients with disease and one healthy control. The authors noted that standard 
constitutive models could not be uniquely constrained by solely comparing predicted and measured 
displacements. Nasopoulou et al., [104] addressed the problem of identifiability with an energy 
based cost function and data from seven patients and one control. Gao et al., [105] applied their 
parameter inference method to three healthy cases. All of these studies used a small number of 
datasets. Extending these approaches to larger clinical populations remains a significant challenge. 
Patient Specific Models: Boundary Conditions 
As models were improved to reproduce detailed clinical and experimental data there was a need to 
move from fixed pressure and volume boundary conditions to dynamic models of aortic resistance. 
Many groups have now adopted the three element Windekessel model that provides a succinct 
representation of the aortic pressure-flow relationship. Kerkhoffs et al., [106] increased the realism 
by coupling their bi-ventricle model to a closed loop cardiovascular system model. To capture the 
interactions between the myocardial wall and blood flow in the cavity, Watanabe et al., [107] 
developed a complex heart model capturing the electrophysiology, mechanics and chamber fluid 
dynamics in a single simulation. Nordsletten et al., [108] continued these developments with a fluid-
structure-interaction model. Only limited work has been performed to assess the impact of the 
pericardium [109] and/or the effects of the mitral valve on cardiac mechanics. These are areas for 
future development.  
Modelling Specific Patients  
There is growing use of computer models in clinical applications [110]. 2011 saw the development of 
electromechanics models of specific patients. Niederer et al., [111] created a model of a patient with 
left bundle branch block and showed how length dependence of tension generation at the 
sarcomere scale could play a significant role in the response to cardiac resynchronisation therapy. 
Aguado-Sierra et al. [112] published a case study demonstrating the creation of a patient specific 
model, while Sermesant et al. [113] presented a method for developing personalised electro-
mechanics models which had been applied to three patients. Crozier et al., [114] created models of 
three patients and used these to study the relative role of patient physiology and device settings in 
response to cardiac resynchronisation therapy. Lee et al., [115] then developed the first personalised 
models that captured patient remodelling in response to therapy to study the effects of pacing 
location repositioning following CRT device implantation. Okada et al., [116] moved from simulating 
1-3 patients to modelling 9 patient hearts, allowing a statistical validation of the virtual cohort. 
Finally, Kayvanpou et al., [117] created a cohort of 50 patient specific electromechanical models and 
found a correlation between model parameters and patient response to CRT.  
Discussion  
Models of cardiac mechanics have developed from early models of skeletal muscle to cardiac specific 
models that explicitly represent selected protein-protein interactions. While the development of 
cardiac models has come a long way there are five gaps identified in this review which require more 
attention: (a) broadening the sarcomeric proteins included in models, (b) understanding the 
similarities and differences between modelling frameworks, (c) representing species specificity, and 
(d) furthering our mechanistic understanding of contraction regulation, and (e) development of 
detailed organ-scale models. 
Cardiac contraction models still contain only a small subset of the proteins present in the sarcomere 
and omit many of the proteins that are associated with inherited cardiomyopathies. Neither have 
cardiac contraction models been developed to a point where they can readily simulate 
pharmacological effects, as has been achieved by the cardiac electrophysiology modelling 
community [118, 119].  
In contrast to cardiac electrophysiology modelling [120], there is a lack of consensus on the best 
modelling framework to simulate the biophysics of the sarcomere. Distinct modelling paradigms 
have been adopted by different groups so that, for example, a model of tropomyosin kinetics 
developed in one context has limited equivalence in another modelling framework. Currently three 
broad modelling approaches are being used: Huxley based partial differential equations, mean field 
systems of ordinary differential equations, and spatially-explicit models that attempt to represent 
each protein. The specific contexts where each framework is most relevant and conditions where 
models are equivalent remains to be determined.  
Species specific models are still in early development. The major constituents of cardiac contractile 
function are consistent across species, however, differences in isoforms and kinetics lead to distinct 
species specific contraction kinetics (for review see [121]). Two forms of myosin heavy chain are 
present in mammalian hearts V1 and V3. V1 is a homodimer of two α-MHC molecules and V3 is a 
homodimer of two β-MHC. Mice and rats predominantly express the faster V1 or α-MHC, whereas 
humans and larger animals express predominantly V3 or β-MHC [122, 123]. Titin content also varies 
between species with the N2B isoform dominating in rats and mice but the N2BA and N2B titin 
isoforms being expressed at comparable levels in humans [124]. Differences in the N-terminal of 
myosin binding protein C are found between species, with smaller animals expressing more proline 
and alanine residuals [125]. Inclusion of these, and other, species specific isoform differences, along 
with the distinct differences in calcium handling dynamics between species [8] will be a critical step 
in the development of models that can be compared directly with experimental data. 
Models are inherently approximations that facilitate understanding. Contractile modelling is 
particularly challenging as the range of measurements needed to constrain the parameters 
in increasingly complex models are not all performed in the same laboratory, requiring 
parameters to be fitted to data from multiple groups recorded under different conditions. 
This means that models are often fitted to distinct permutations of experimental data. In 
addition, models fitted to different data sets will exhibit distinctly different characteristics, 
not due to model failure, but due to differences in the underlying data. For example, data 
fitted to steady state force-calcium relationship from [20] will have fit a single Hill curve with 
a length dependent cooperativity. In contrast models fit to data from [21] will have a length 
independent cooperativity but two Hill coefficients corresponding to high and low calcium. 
Models are also limited by gaps in our understanding of physiological mechanisms. 
Specifically, models often use phenomenological representations of the length dependence 
of calcium sensitivity, in part because the molecular mechanisms are incompletely 
understood [24]. At the same time, as happened with crossbridges, models may generate a 
testable hypothesis to explain this mechanism.Organ scale models now link down to cellular 
mechanics and are increasingly tailored to represent the physiology and pathology of specific 
patients. Early work in organ scale modelling required specific code to solve the equations of large 
deformation. Now multiple codes are available to solve the standard systems [126]. Cardiac models 
still face significant computational challenges but key technical questions that also need to be 
addressed include how to infer model parameters from clinical data, how to incorporate uncertainty 
and missing clinical data in model creation, and how to represent boundary conditions. 
Clinical data are being generated at ever increasing rates. Computer models of cardiac contraction 
will have an important role to play in integrating and interpreting these data, and to link molecular 
and cellular observations through to whole organ pump function. 
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Our understanding and enjoyment of cardiac contraction modelling has been informed and 
furthered by many useful and thoughtful discussions with Dr Jeremey Rice. He will be missed. 
 
Figure Captions: 
Figure 1: Functional properties of isolated myocardium.  Panels show examples (in schematic form) 
of: A) the force-velocity relationship, B) isometric twitch, C) length-dependent changes in Ca2+-
dependent force, D) force response to step length changes, and E) sinusoidal analysis. 
 
Figure 2: Timelines showing the development of cardiac muscle models in relation to several of the 
key discoveries in striated and cardiac muscle physiology.  
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